Published in Cell on April 10, 2014
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature (2015) 3.64
Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell (2014) 2.30
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature (2016) 2.27
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell (2016) 2.27
Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell (2015) 2.06
Cancer stem cells in glioblastoma. Genes Dev (2015) 1.91
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell (2016) 1.74
Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells. PLoS Biol (2015) 1.51
Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma. Cancer Cell (2016) 1.49
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. Science (2016) 1.44
Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med (2017) 1.40
MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes. Genome Biol (2014) 1.09
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet (2016) 1.06
SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Reports (2015) 1.06
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis (2015) 1.05
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res (2015) 1.02
miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J Clin Invest (2014) 1.02
Role of SOX family of transcription factors in central nervous system tumors. Am J Cancer Res (2014) 1.01
Cancer stem cell plasticity and tumor hierarchy. World J Stem Cells (2015) 0.96
Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell (2016) 0.94
A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Rep (2015) 0.94
Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest. Stem Cell Reports (2015) 0.93
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget (2015) 0.93
Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation. Cell Rep (2014) 0.92
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell (2015) 0.91
Differential connexin function enhances self-renewal in glioblastoma. Cell Rep (2015) 0.91
FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. PLoS One (2015) 0.90
CDC20 maintains tumor initiating cells. Oncotarget (2015) 0.90
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nat Commun (2015) 0.90
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res (2015) 0.89
Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med (2015) 0.89
The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget (2015) 0.89
Development of a Sox2 reporter system modeling cellular heterogeneity in glioma. Neuro Oncol (2014) 0.88
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. Cancer Res (2016) 0.87
Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest (2016) 0.87
Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway. Cell Rep (2016) 0.87
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype. Nat Commun (2015) 0.86
An epigenetic gateway to brain tumor cell identity. Nat Neurosci (2015) 0.85
WNT signaling in glioblastoma and therapeutic opportunities. Lab Invest (2015) 0.84
The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches. Cell Rep (2016) 0.84
An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells. J Neurosci (2014) 0.84
Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity. Dis Model Mech (2015) 0.83
Brain neoplasms and coagulation-lessons from heterogeneity. Rambam Maimonides Med J (2014) 0.83
Uncovering the roles of long noncoding RNAs in neural development and glioma progression. Neurosci Lett (2015) 0.83
Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev (2015) 0.83
Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun (2016) 0.82
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. Expert Opin Ther Targets (2016) 0.82
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22. Nat Cell Biol (2016) 0.82
Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC). Apoptosis (2014) 0.82
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell (2016) 0.82
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nat Neurosci (2017) 0.81
Paradoxical role of SOX2 in gastric cancer. Am J Cancer Res (2016) 0.81
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Oncogene (2015) 0.81
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal. Oncotarget (2016) 0.81
Connect four with glioblastoma stem cell factors. Cell (2014) 0.81
Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network. Nat Commun (2016) 0.81
Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene (2016) 0.80
Deregulated proliferation and differentiation in brain tumors. Cell Tissue Res (2014) 0.80
Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes. Int J Cancer (2015) 0.80
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proc Natl Acad Sci U S A (2015) 0.80
A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2. Cell Rep (2017) 0.80
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature (2017) 0.79
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun (2016) 0.79
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol (2015) 0.79
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep (2017) 0.79
ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis. J Natl Cancer Inst (2015) 0.78
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy. Stem Cells Int (2016) 0.78
EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas. Epigenetics (2015) 0.78
Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin. Cell Death Dis (2015) 0.78
BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells. Sci Rep (2016) 0.78
Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma. Oncotarget (2016) 0.78
Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells. Cell Rep (2016) 0.77
Induced pluripotent stem cell technology for dissecting the cancer epigenome. Cancer Sci (2015) 0.77
Reprogramming strategies for the establishment of novel human cancer models. Cell Cycle (2016) 0.77
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation. J Clin Invest (2016) 0.77
Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles (2015) 0.77
LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain. Nat Commun (2016) 0.76
Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction. Nucleic Acids Res (2016) 0.76
Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res (2015) 0.76
Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer. Sci Rep (2016) 0.76
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat Commun (2016) 0.76
Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. J Exp Med (2016) 0.76
Radioresistance of Brain Tumors. Cancers (Basel) (2016) 0.76
ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation. Oncotarget (2016) 0.76
Sox2, a marker for stem-like tumor cells in skin squamous cell carcinoma and hedgehog subgroup medulloblastoma. EMBO J (2014) 0.76
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma. Front Oncol (2016) 0.76
The role of octamer binding transcription factors in glioblastoma multiforme. Biochim Biophys Acta (2016) 0.76
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes. PLoS One (2016) 0.76
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. BMC Genomics (2017) 0.76
CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study. Oncotarget (2016) 0.76
Chromatin module inference on cellular trajectories identifies key transition points and poised epigenetic states in diverse developmental processes. Genome Res (2017) 0.76
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients. Nat Commun (2016) 0.75
Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance. Neurochem Res (2016) 0.75
Differentiation therapy for glioblastoma - too many obstacles? Mol Cell Oncol (2015) 0.75
Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas. Mol Syst Biol (2016) 0.75
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer? Am J Cancer Res (2016) 0.75
Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Neuro Oncol (2016) 0.75
An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci U S A (2016) 0.75
Resetting cancer stem cell regulatory nodes upon MYC inhibition. EMBO Rep (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature (2009) 18.38
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13
A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2010) 14.02
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet (2008) 11.17
A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 8.88
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell (2005) 5.74
Functional and mechanistic diversity of distal transcription enhancers. Cell (2011) 5.22
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
Cancer stem cells: current status and evolving complexities. Cell Stem Cell (2012) 5.07
Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science (2012) 4.14
Cancer stem cells: lessons from leukemia. Trends Cell Biol (2005) 3.90
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell (2009) 3.89
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell (2010) 3.82
Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol (2013) 3.82
PML targeting eradicates quiescent leukaemia-initiating cells. Nature (2008) 3.75
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell (2010) 3.69
Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell (2013) 3.61
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells (2009) 3.54
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A (2012) 3.52
Epigenetic reprogramming in cancer. Science (2013) 3.47
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell (2010) 3.34
Predictive chromatin signatures in the mammalian genome. Hum Mol Genet (2009) 3.25
Chromatin connections to pluripotency and cellular reprogramming. Cell (2011) 3.07
Transcriptional regulation and its misregulation in disease. Cell (2013) 2.92
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res (2009) 2.74
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell (2012) 2.50
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 2.38
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell (2012) 2.26
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol (2010) 1.98
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell (2011) 1.92
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev (2013) 1.88
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev (2012) 1.64
Noncanonical transcript forms in yeast and their regulation during environmental stress. RNA (2010) 1.59
The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell (2012) 1.50
A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res (2013) 1.50
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell (2013) 1.44
Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . Biochemistry (2010) 1.36
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep (2013) 1.35
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. Cell Rep (2014) 1.34
SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. PLoS Genet (2013) 1.32
RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency. Stem Cells (2011) 1.27
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma. Cancer Res (2013) 0.97
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (2017) 0.85
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell (2016) 0.82
Defining the 5΄ and 3΄ landscape of the Drosophila transcriptome with Exo-seq and RNaseH-seq. Nucleic Acids Res (2017) 0.76
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell (2017) 0.75